SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: PURDUE PHARMA LP, PURDUE PHARMA LP, PURDUE PHARMA, LP
Client-Reported Lobbying Expenses
$18.5M
113 filings
Firm Income Reported for This Client
$420K
Not substituted for client expenses
Contract Awards
$281K
113 awards
Summary
PURDUE PHARMA, LP is an organization, based in CT. Its political footprint includes $18.5 million in client-reported lobbying expenses, $420K in lobbying-firm income reported for this client, $281K in government contracts. Lobbying activity focuses on Health Issues, Alcohol and Drug Abuse, Copyright/Patent/Trademark, Medicare/Medicaid. Their largest government contract source is Department of Defense at $226K. Political activity spans from 2001 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 0% YoY
2025: $400K (complete years)
Political Money Flow
Government agencies → PURDUE PHARMA, LP (contracts) → political recipients & lobbying. Hover for details.
Activity data: Senate LDA · USAspending.gov